In particular, miR-223, together with miR-126, miR-140, and miR-26b are expressed at a lower level in both platelets and megakaryocytes from T2DM patients, leading to upregulation of P2Y12 receptor and SELP (P-selectin), thus contributing to platelet hyperactivation (34). Here, SELP is linked to type 2 diabetes mellitus.